In early November, one of the largest international events in the pharmaceutical industry took place - CPhI (Convention of Pharmaceutical Ingredients). This year the exhibition was held in Frankfurt, Germany. Traditionally, it brought together the largest representatives of the pharmaceutical business from around the world.
Companies that meet international standards and are considered industry leaders take part in the exhibition. Its goal is to establish partnerships between participants, develop the international pharmaceutical community and open up new business opportunities. Farmak, as the leader of the Ukrainian pharmaceutical market and the largest domestic exporter, has traditionally joined the event.
Farmak is one of the 1000 largest pharmaceutical companies in the world. The company is certified by European regulatory authorities, which allows it to increase its export potential and sell products in markets with particularly stringent requirements for the quality and safety of medicines. The company's products are exported to more than 50 countries in the EU, Central and South America, the CIS, the Middle East, and Asia.
This year, Farmak's booth was decorated with ears of wheat and Ukrainian ornaments as a reminder to the world of the invincibility of the Ukrainian people and business, as well as Ukraine's struggle for its independence.
Ukraine's largest drug manufacturer Farmak is investing more than 20 million euros in a new factory of its own drugs in the suburbs of Barcelona. The plant, with a complete supply chain, closed production cycle, and quality control, is scheduled to open in early 2024. It will produce sterile medicines in the form of solutions, […]
Pharmaceutical company Farmak paid more than UAH 550 million in taxes to the budgets of all levels for 9 months of 2022. In order to support the state, the enterprise paid the first amount of UAH 105.8 million in advance, immediately after the start of the war. According to Proxima Research, as of November 2022, […]
Despite the war, Ukraine's largest pharmaceutical company, Farmak, opened a new production site for medicines in nebules and launched 11 new products on the market. These are medicines for the treatment of respiratory tract and bronchial asthma, thrombosis, and acute myocardial infarction, as well as radiocontrast, anti-inflammatory and analgesic medic...
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Farmak PAT published this content on 24 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2022 11:33:04 UTC.